Objective: To assess the prevalence and outcome of external cerebral ventricular drainage-associated ventriculitis in neurocritical patients before and after the implementation of a bundle of external cerebral ventricular drainage-associated ventriculitis control measures. Design: Clinical prospective case series. Setting: University Hospital of Larissa, Greece. Patients: Consecutive patients were recruited from the ICU of the hospital. Patient inclusion criteria included presence of external ventricular drainage and ICU stay more than 48 hours. Intervention: The bundle of external cerebral ventricular drainageassociated ventriculitis control measures included 1) reeducation of ICU personnel on issues of infection control related to external cerebral ventricular drainage, 2) meticulous intraventricular catheter handling, 3) cerebrospinal fluid sampling only when clinically necessary, and 4) routine replacement of the drainage catheter on the seventh drainage day if the catheter was still necessary. The bundle was applied after an initial period (preintervention) where standard policy for external cerebral ventricular drainage-associated ventriculitis was established.
infection rates (DA-IR) may vary between 6.3 and 22.4 infections per 1,000 drainage days (DD) (4, 5) . Those studies have also reported that ventriculitis may be associated with considerable nosocomial morbidity (2) (3) (4) 6) . However, data on the long-term outcome for neurocritical patients with external cerebral ventricular drainage-associated ventriculitis (EVDV) are limited.
Furthermore, it should be underlined that EVDV is a hospital infection that may be caused by multidrug-resistant (MDR) bacteria that are associated with adverse outcomes (7) . Notably, recent data point out a shift in the etiology of ICU infections with Gram-negative MDR pathogens and some of them, such as the Acinetobacter baumannii and Klebsiella pathogens (3, 5, (7) (8) (9) (10) may result in devastating infections.
In this prospective study, we therefore aimed to assess ventriculitis and to study outcome and disability indices in neurocritical patients admitted in ICU due to cerebral hemorrhage or brain trauma, in the era of MDR Gram-negative microorganisms (11) . We studied two consecutive periods, before and after the implementation of a bundle of EVD infection control measures.
METHODS

Design and Population
Consecutive sampling was used to recruit critical care patients. Inclusion criteria were presence of EVD for at least 1 day and ICU stay more than 48 hours. Exclusion criteria were age less than 18 years, pregnancy, lumbar drainage, transfer from other ICU, previous EVDV diagnosis, or previous placement of cerebral ventricular catheter. A total of 212 patients hospitalized during the recruitment period were assessed for eligibility.
The study took place in the ICU of the University Hospital of Larissa (12 beds) between 2007 and 2012. Initially, we assessed clinical and microbiologic data from January 2007 to December 2009 to study risk factors associated with ventriculitis; we noted that infection was diagnosed at median (interquartile range [IQR] ) (12 [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ) ICU day and that there was no independent risk factor for ventriculitis. Subsequently, during a second period between January 2010 and January 2012, we implemented a bundle of EVDV-specific infection control measures. The bundle was based on published data (5, (12) (13) (14) (15) adjusted on local protocols and setting. The bundle included 1) reeducation of ICU personnel (nurses, trainees, doctors, and physiotherapists) on issues of infection control related to EVD including a) presentations related to infection control and particularly CNS and EVD infection in the ICU-presentations were scheduled twice monthly during a 3-month period and the program was repeated twice, b) meetings with agenda related to bacterial epidemiology in the ICU, EVD handling, and program evolution, and c) audits; 2) meticulous EVD catheter handling with respect to EVD covering, dressing for wound exit site, hand hygiene, barrier precautions whenever opening the connecting three-way valve, flushing of the peripheral part of EVD for unblocking and cleaning standards; 3) cerebrospinal fluid (CSF) sampling only when clinically necessary (aiming at less than twice weekly); and 4) routine replacement of the drainage catheter on the seventh DD if the catheter was still necessary (supplemental data, Supplemental Digital Content 1, http://links.lww.com/CCM/A708). The study was approved by the Internal Review Board and Ethics Committee of the University of Larissa.
Outcomes EVDV prevalence (% of patients) was assessed as primary outcome in this study. Ventriculitis infection events per 1,000 DD (DA-IR), length of ICU stay, disability described by the Glasgow Outcome Scale (GOS) (16) at 6 months, and identification of risk factors for EVDV were assessed secondarily.
Clinical Assessment, Microbiology, and EVD-Related Procedures
Baseline clinical and demographic characteristics were recorded. Quantitative cultures, quality assessment, cytology, and biochemistry (protein, lactate dehydrogenase, and glucose levels) of CSF were performed at physicians' discretion. Blood tests, C-reactive protein serum levels, cell counts, and microbiologic blood examination were performed routinely on a daily basis when the patient was considered to be infected. CSF sampling was carried out by aseptic technique.
External ventricular catheters (EVD) were inserted under sterile conditions in the operating theater. A standard commercially available external drainage system with ventricular catheter and microsensor kit was used for the EVD. Neither antibiotic nor silver impregnated catheters were used. A written protocol was followed for drainage placement, and the preferred insertion point of the catheter was the Kocher entry point-usually the right side if technically feasible (supplemental data, Supplemental Digital Content 1, http://links. lww.com/CCM/A708). With respect to the technique used in catheter replacement, there was standard recommendation for using the other side or another site on the same side if technically possible. The standard institutional policy for perioperative antibiotic prophylaxis was followed. Thus, prophylactic antibiotics were provided perioperatively (ceftriaxone and teicoplanin were given prophylactically 30 minutes prior to and 6-8 hr after insertion) in all patients for the placement of the first EVD catheter and not continuously during the drainage period. There was no recommendation for antibiotic prophylaxis thereafter including any required replacement of the EVD catheter.
Infection control policy included isolation techniques in patients with MDR bacteria, written antibiotic treatment protocol, and continuous surveillance of nosocomial infections. Sedation and ventilator weaning procedures were standard throughout the whole study period. Oral decontamination was performed daily with the use of hexitidine, whereas we do not use prophylactic local antibiotics as part of selective oropharyngeal or selective digestive decontamination. Respiratory circuits were not routinely changed. Compliance in the bundle of measures was assessed by evaluating certain items related to control measures (hand hygiene compliance 
Definitions
Ventriculitis was defined according to the Centers for Disease Control and Prevention definition (17) either with the detection of a pathogen in the CSF or the combination of at least one typical clinical sign indicating ventriculitis plus pathologic CSF findings (elevated cell count and/or decreased glucose level).
GOS defines five categories: 1) death, 2) vegetative state, 3) severe disability: although the patient can follow commands, cannot live independently, 4) moderate disability: although the patient can live independently, cannot return to school or work, and 5) good recovery: the patient can return to work or school (16) . Favorable and unfavorable neurologic outcome were defined as GOS 4-5 and 1-3, respectively (18) .
We considered MDR bacteria to be those resistant to the following three antibiotic categories: third-generation cephalosporins, antipseudomonal penicillins, and quinolones (19) .
Statistics
Results are presented as frequency (%) for qualitative variables or mean (95% CI) for quantitative variables. Qualitative variables were compared using chi-square test or Fisher exact test where appropriate. Student t test or Mann-Whitney U tests were used to compare quantitative variables. Univariate analyses were performed to determine variables associated with EVDV (positive or negative) or prolonged ICU stay (less than or more than of median stay). The statistical tests were two sided. A result was considered statistically significant when p value is less than 0.05. Analysis was performed using statistical 
RESULTS
A total of 212 patients were screened, and 139 patients fulfilled inclusion criteria and entered the study ( Fig. 1) : 82 patients (112 EVDs) entered the study during the first period (preintervention) and 57 patients (93 EVDs) during the second period (intervention). Baseline characteristics of participants are shown in Table 1 .
DDs were 1,280 and 867 in the first and second periods, respectively, and mean (95% CI) DDs per patient were 15.6 (13.2-18) and 15.2 (12.5-18.7, p = 0.91) in the first and second periods, respectively. Compliance in infection control measures during the intervention period was 85% overall. EVD catheters were replaced 11.2 days (9.7-12.7 d) and 8.4 days (7.4-9.4 d) after insertion during the first and the second periods, respectively (p = 0.007). Compliance in EVD replacement (routine replacement after 7 d of drainage) was achieved in 62% of cases. In cases of catheter replacement, 29 of 30 patients in the preintervention period and 30 of 36 patients in the intervention period (p = 0.12) were on empirical or targeted antibiotic treatment for reasons other than catheter replacement in accordance with decisions made by the treating physicians.
Outcomes
Overall, EVDV was diagnosed in 29 patients; mean (95% CI) day of diagnosis was 12.8 days (9.9-15.8 d). During the preintervention period, 23 of 82 patients (28%) presented EVDV, whereas during the intervention period, 6 of 57 patients (10.5%) presented EVDV (p = 0.02). DA-IR was 18 and 7.1 during the preintervention and intervention periods, respectively; ventriculitis DD and nonventriculitis DD were 592 and 688 and 116 and 751 during the preintervention and intervention periods, respectively (p < 0.001). Characteristics of patients with EVDV in both periods are shown in Table 2 .
The length of drainage in patients with EVDV was significantly longer compared with that in patients who did not present EVDV (26 d ICU stay was also associated with length of EVD maintenance (p = 0.0001) but with no other clinical or microbiologic variables ( Table 3) . Length of ICU stay in the preintervention and intervention periods was 27.1 (22.5-31.7) and 22.3 (17.4-27.3), respectively (p = 0.19). According to 6-month GOS evaluation, unfavorable neurologic outcome (GOS 1-3) was present in 16 of 29 patients with ventriculitis (55.2%), whereas unfavorable neurologic outcome was noted in 66 of 107 patients (61.7%) who did not presented ventriculitis (p = 0.5). No differences were found when GOS was analyzed according to the study period ( Table 4 ) or according to subcategory of admission diagnosis (Supplemental Table 3 , Supplemental Digital Content 1, http://links.lww.com/CCM/ A708).
Overall, ICU, hospital, and 6-month mortality among participants were 22.3%, 40.2%, and 46.7%, respectively. There were 11 ICU deaths among 23 patients (47.8%) who presented EVDV during the preintervention period, whereas during the period of intervention, there were two deaths among patients with EVDV (33%).
Clinical Assessment and Microbiology
The bacteria isolated in CSF are shown in Table 5 . Overall, A. baumannii was most frequently found (44.8% of all cases), followed by carbapenemase-producing Klebsiella pneumoniae. There was no association between isolated microorganisms and cause of admission in terms of neurocritical illness. Microorganisms isolated by admission diagnosis are shown in Supplemental Table 2 Five patients (four in the preintervention and one in the intervention periods) presented the same isolate (A. baumannii) in CNS either in blood (one patient) or in sputum (four patients: two fulfilled criteria for ventilator-associated pneumonia and two were diagnosed as bronchial colonization) before EVDV. There was no significant statistical difference between the two periods, and no difference was found in terms of outcomes between those five patients and the other patients with ventriculitis.
All 29 patients with EVDV received IV treatment. Sixteen of 21 microbiologically confirmed patients (76.2%) received appropriate IV antibiotic therapy either before or on the day of diagnosis. the first period and one of 6 patients (16.6%) in the second period, respectively (p = 0.005).
DISCUSSION
The main findings of the present investigation were 1) EVDV had an adverse impact in neurocritical morbidity and ICU stay was significantly prolonged in patients who presented EVDV compared with patients without EVDV and 2) the implementation of a bundle of infection control measures was associated with a significant reduction in the prevalence of EVDV, and we found that there was an indication toward shorter hospitalization in the ICU during the period of the implementation of the bundle. Despite the aforementioned improvements, the 6-month outcome (based on the GOS) was not different between the intervention and the preintervention period. EVDV is a severe hospital infection with potentially adverse impact on morbidity in terms of increased hospital stay and its related costs (3, 8, 20) . However, data regarding the impact of ventriculitis on patients' neurologic outcome are limited. A previous investigation reported a significant association between severe in-hospital neurologic impairment and ventriculitis (3), but there was no data regarding the impact of ventriculitis on the long-term outcome. On the other hand, data from a large cohort (2) suggested that in-hospital infections may adversely affect patients with subarachnoid hemorrhage (SAH) by increasing the length of hospital stay and the odds of a poor outcome. Nevertheless, ventriculitis cases were few in that cohort study, and no particular information was given regarding the effect of ventriculitis on the neurologic outcome of patients with SAH.
In our study, the length of stay was significantly prolonged in patients who presented EVDV compared with patients who did not. This does not necessarily imply a causal relationship as other factors might also have an impact on the length of ICU stay. We, therefore, aimed to evaluate the association between ICU stay and several other clinical and microbiologic factors. Indeed, the duration of external ventricular drainage was also significantly associated with ICU stay (Table 3) . We aimed to minimize drainage duration, and our bundle of measures included daily evaluation of the necessity to keep EVD in place (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/A708). Additionally, EVD was not in itself a criterion for continued hospitalization in the ICU. However, the potential adverse impact of a long drainage duration on the length of ICU stay cannot be excluded.
The implementation of a bundle of infection control measures in our study significantly reduced the prevalence of EVDV by 57%. By applying the bundle, we aimed to reinforce infection control policy, to increase awareness of potential ways of infection transmission, and to highlight the importance of keeping a strict control protocol. Furthermore, we attempted to improve handling of the catheter and to replace the catheter at the recommended time. Leading infectious disease organizations have underlined the usefulness of the implementation of bundle of measures for reducing the frequency of ICU infections (21), but strict universally accepted guidelines, especially for EVD, do not exist. Previous investigators have suggested similar measures for controlling EVDV, such as proper insertion (under antimicrobial prophylaxis and using standard operating protocols), aseptic handling of the EVD, and minimization of CSF sampling (22, 23) . However, the use of a bundle of measures does not specifically identify if some components are more important than others. In our bundle, we applied several previously suggested measures including regular change of EVD catheters every 7 days. The decision for catheter changing after this particular time was based on previous suggestions (14) and on preintervention data from our center (day of EVDV diagnosis at median [IQR] 12 days [7-19 d] form EVD placement). Mayhall et al (14) in a large prospective epidemiological analysis of 172 consecutive cases suggested that EVD should be changed every 5 days. Previous investigations demonstrated that infection risk peaks at about the seventh to ninth day of drainage (9, 24) and that cumulative infection risk (which corrects for censoring of data) increased daily throughout drainage duration (24, 25) . Bacteria may gain entry around the catheter and may form a biofilm along the lumen of the catheter, which might be hard to eradicate without catheter removal (26, 27) . This might be especially true in cases of a longstanding drainage catheter (8, 25) . We therefore aimed to regularly replace the EVD catheter in our study. Other investigators suggested that routine catheter change might not be beneficial (24, 28) and could even be harmful (29) . Hence, although strict infection control and aseptic insertion, handling, and sampling can be widely accepted, optimum EVD duration and catheter change are still a matter of debate. The implementation of the bundle reduced the duration of ICU stay during the intervention period compared with the previous period in this study (Table 4) ; however, this difference did not reach statistical significance. In addition, there was no evidence of an association between the implementation of the bundle and the GOS at 6 months. Our findings were similar when the population was broken down into subcategories according to admission causes, neurosurgical interventions, or microbiology (supplemental data, Supplemental Digital Content 1, http://links.lww.com/ CCM/A708). The most plausible explanation is that these outcomes could also be affected by other events or infections that may have occurred in the ICU before or after EVDV-or by the duration of drainage, as explained previously. It can be also argued that as an outcome measure, GOS is a relatively blunt instrument and more subtle differences may have been missed. However, we used GOS as it is considered a standard outcome measure in this setting (30, 31) .
Our study also found that EVDV cases were more commonly caused by Gram-negative microorganisms. The major pathogen was carbapenem-resistant A. baumannii, which was present in 75% of culture-positive cases. Many recent ventriculitis studies show a predominance of Gram-negative bacteria (3, 5, (7) (8) (9) . In an era where bacterial resistance is growing globally, these facts underline that MDR Gram-negative bacteria have become a major public health issue (11, 32) . Previous investigation (7) pointed out that MDR bacteria may be associated with increased mortality in neurocritical patients. In our study, MDR bacteria were not associated with increased mortality. One explanation for this discrepancy might be treatment differences. Intraventricular antibiotics were extensively used (76%) in the study. Intraventricular treatment is a common strategy for EVDV in our institution. Notably, we use intraventricularly colistin in most cases where A. baumannii is the main causative agent for ventriculitis. Although the effect of this type of treatment on ventriculitis outcome is not established and there is no widely accepted guideline on this issue (33, 34) , there are data suggesting that this type of treatment may contribute to the eradication of A. baumannii (34, 35) . Whether this type of treatment can significantly affect EVDV outcome, however, remains elusive.
There are some points that should be considered in the interpretation of the results of this study. The design was a "before" and "after" intervention case series, so it is prospective; one might argue whether a randomized trial would be feasible for this issue. On this basis, there was awareness of the intervention being implemented. This might have lead to increased compliance with the bundle elements applied which, in turn, might have enhanced the effectiveness of the bundle (36) .
Outcomes were similar among different subpopulations of patients with ventricular drains. This is in agreement with previous investigations which did not report an association between the frequency of ventriculitis and admission diagnosis and the presence of craniotomy (3, 5, 8, 9) . However, definitive conclusions for such associations are hard to be drawn from the present one-center study which was not empowered to differentiate subpopulations with ventricular catheters who may be more at risk of infection; larger prospective multicenter investigations are needed to shed more light on this issue.
Finally, it should be clarified that intraventricular treatment was not part of the bundle, and it was not a guide for the duration of EVD. It was guided by clinical criteria related to the underling condition of the patient, and the principle was to withdraw the catheter as soon as clinical problems were resolved; a relevant recommendation was included in the bundle.
In conclusion, our study implies that decreasing the prevalence of ventriculitis in neurocritical patients is feasible by the implementation of a bundle of measures for EVDV control, even in the era of MDR microbes. Furthermore, our data suggest that regular change of EVD catheters after 7 days of drainage might be not harmful and may be associated with decreased morbidity in neurocritical patients.
